LAB

Standard BioTools Inc.

LAB · CIK 1162194 · Annual (10-K) · Last 8 years

Financial Trends

Revenue$174M
20172024
Net Income−$139M
20172024
Operating CF−$143M
20172024
Free Cash Flow−$152M
20172024

Income Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕FY 2017↕
Revenue$0.2B$0.1B$0.1B$0.1B$0.0B$0.0B$0.0B$0.0B
Cost of Revenue$0.1B$0.1B———$0.1B$0.1B—
Gross Profit$0.1B$0.1B——$0.0B$0.1B$0.1B—
R&D Expense$0.1B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
SG&A Expense$0.2B$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B
Operating Income$-0.2B$-0.1B$-0.1B$-0.1B$-0.1B$-0.1B$-0.0B$-0.1B
Net Income$-0.1B$-0.1B$-0.2B$-0.1B$-0.1B$-0.1B$-0.1B$-0.1B
EPS (Basic)$-0.52$-0.94$-2.43$-0.78————
EPS (Diluted)$-0.52$-0.94$-2.43$-0.78————

Balance Sheet

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕FY 2017↕
Total Assets$0.6B$0.3B$0.4B$0.3B$0.3B$0.3B$0.3B$0.3B
Current Assets$0.4B$0.2B$0.2B$0.1B$0.1B$0.1B$0.1B$0.1B
Cash & Equivalents$0.2B$0.1B$0.1B$0.0B$0.1B$0.0B$0.1B$0.1B
Total Liabilities$0.1B$0.2B$0.2B$0.2B$0.2B$0.1B$0.2B$0.3B
Current Liabilities$0.1B$0.1B$0.0B$0.0B$0.1B$0.0B$0.0B$0.0B
Stockholders' Equity$0.5B$-0.1B$-0.1B$0.1B$0.1B$0.2B$0.1B$0.0B

Cash Flow Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕FY 2017↕
Operating Cash Flow$-0.1B$-0.0B$-0.1B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B
Investing Cash Flow$0.4B$0.0B$-0.1B$-0.0B$0.0B$-0.0B$0.0B$0.0B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$-0.1B$-0.0B$0.2B$0.0B$0.0B$0.0B$0.1B$0.0B
← Companies